KLSE:LKL

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

LKL International Berhad

Market Cap

RM153.0m

Last Updated

2021/07/30 18:11 UTC

Data Sources

Company Financials

Executive Summary

LKL International Berhad, an investment holding company, manufactures and sells medical and healthcare beds, medical peripherals, and related accessories under the LKL brand name in Malaysia. More Details


Snowflake Analysis

Adequate balance sheet and overvalued.

Share Price & News

How has LKL International Berhad's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: LKL is more volatile than 75% of MY stocks over the past 3 months, typically moving +/- 10% a week.

Volatility Over Time: LKL's weekly volatility has decreased from 17% to 10% over the past year, but is still higher than 75% of MY stocks.


Market Performance


7 Day Return

-11.5%

LKL

-6.5%

MY Medical Equipment

-1.0%

MY Market


1 Year Return

-69.1%

LKL

-60.3%

MY Medical Equipment

-0.7%

MY Market

Return vs Industry: LKL underperformed the MY Medical Equipment industry which returned -60.3% over the past year.

Return vs Market: LKL underperformed the MY Market which returned -0.7% over the past year.


Shareholder returns

LKLIndustryMarket
7 Day-11.5%-6.5%-1.0%
30 Day0%-3.6%-0.4%
90 Day-20.6%-31.9%-5.9%
1 Year-69.1%-69.1%-57.5%-60.3%3.0%-0.7%
3 Year58.8%58.8%88.7%72.7%-2.8%-12.0%
5 Year-2.3%-3.6%341.7%288.8%9.8%-8.7%

Long-Term Price Volatility Vs. Market

How volatile is LKL International Berhad's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is LKL International Berhad undervalued compared to its fair value and its price relative to the market?

1.17x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate LKL's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate LKL's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: LKL is unprofitable, so we can't compare its PE Ratio to the MY Medical Equipment industry average.

PE vs Market: LKL is unprofitable, so we can't compare its PE Ratio to the MY market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate LKL's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: LKL is good value based on its PB Ratio (1.2x) compared to the MY Medical Equipment industry average (2.6x).


Future Growth

How is LKL International Berhad forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

17.4%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as LKL International Berhad has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has LKL International Berhad performed over the past 5 years?

-21.1%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: LKL is currently unprofitable.

Growing Profit Margin: LKL is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: LKL is unprofitable, and losses have increased over the past 5 years at a rate of 21.1% per year.

Accelerating Growth: Unable to compare LKL's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: LKL is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (41.4%).


Return on Equity

High ROE: LKL has a negative Return on Equity (-3.2%), as it is currently unprofitable.


Financial Health

How is LKL International Berhad's financial position?


Financial Position Analysis

Short Term Liabilities: LKL's short term assets (MYR89.2M) exceed its short term liabilities (MYR5.8M).

Long Term Liabilities: LKL's short term assets (MYR89.2M) exceed its long term liabilities (MYR7.0M).


Debt to Equity History and Analysis

Debt Level: LKL's debt to equity ratio (4.7%) is considered satisfactory.

Reducing Debt: LKL's debt to equity ratio has reduced from 23.5% to 4.7% over the past 5 years.

Debt Coverage: LKL's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if LKL's interest payments on its debt are well covered by EBIT.


Balance Sheet


Dividend

What is LKL International Berhad current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate LKL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate LKL's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if LKL's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if LKL's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: LKL is not paying a notable dividend for the MY market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of LKL's dividend in 3 years as they are not forecast to pay a notable one for the MY market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.5yrs

Average management tenure


CEO

Ming Lim (39 yo)

1.5yrs

Tenure

Mr. Ming Chang Lim serves as Executive Director at Focus Dynamics Group Berhad since April 30, 2021. He serves as Executive Director at LKL International Berhad since November 16, 2020. He is a Promoter of...


Leadership Team

Experienced Management: LKL's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.


Board Members

Experienced Board: LKL's board of directors are not considered experienced ( 0.5 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 32.2%.


Top Shareholders

Company Information

LKL International Berhad's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: LKL International Berhad
  • Ticker: LKL
  • Exchange: KLSE
  • Founded: 2015
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: RM153.030m
  • Shares outstanding: 566.78m
  • Website: https://www.lklbeds.com

Number of Employees


Location

  • LKL International Berhad
  • Wisma LKL
  • No. 3, Jalan BS 7/18
  • Seri Kembangan
  • Selangor
  • 43300
  • Malaysia

Listings


Biography

LKL International Berhad, an investment holding company, manufactures and sells medical and healthcare beds, medical peripherals, and related accessories under the LKL brand name in Malaysia. The company o...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/07/30 18:11
End of Day Share Price2021/07/30 00:00
Earnings2021/04/30
Annual Earnings2021/04/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.